MYRIAD GENETICS INC Quarterly Costs and Expenses in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Myriad Genetics Inc quarterly/annual Costs and Expenses history and growth rate from Q1 2010 to Q3 2024.
  • Myriad Genetics Inc Costs and Expenses for the quarter ending September 30, 2024 was $233M, a 7.42% decline year-over-year.
  • Myriad Genetics Inc Costs and Expenses for the twelve months ending September 30, 2024 was $939M, a 7.23% decline year-over-year.
  • Myriad Genetics Inc annual Costs and Expenses for 2023 was $1.01B, a 23.4% increase from 2022.
  • Myriad Genetics Inc annual Costs and Expenses for 2022 was $819M, a 7.05% decline from 2021.
  • Myriad Genetics Inc annual Costs and Expenses for 2021 was $881M, a 4.05% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $939M $233M -$18.7M -7.42% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $958M $248M -$49.2M -16.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $1.01B $230M -$3.3M -1.41% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $1.01B $228M -$2M -0.87% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $1.01B $252M +$50.6M +25.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $962M $297M +$100M +50.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $862M $233M +$42.9M +22.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $819M $230M +$26.1M +12.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $793M $201M -$45.8M -18.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $839M $197M -$13.1M -6.23% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $852M $191M -$29.3M -13.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $881M $204M +$1.1M +0.54% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $880M $247M +$62.4M +33.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $818M $210M +$48.7M +30.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $769M $220M -$77.9M -26.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $847M $203M -$1.1M -0.54% Oct 1, 2020 Dec 31, 2020 10-KT 2021-03-16
Q3 2020 $848M $185M -$22.4M -10.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $870M $162M -$59.5M -26.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $930M $298M +$87M +41.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $843M $204M -$6.8M -3.23% Oct 1, 2019 Dec 31, 2019 10-KT 2021-03-16
Q3 2019 $850M $207M +$6.1M +3.03% Jul 1, 2019 Sep 30, 2019 10-KT 2021-03-16
Q2 2019 $844M $221M +$44.9M +25.5% Apr 1, 2019 Jun 30, 2019 10-KT 2021-03-16
Q1 2019 $799M $211M +$41.4M +24.5% Jan 1, 2019 Mar 31, 2019 10-KT 2021-03-16
Q4 2018 $757M $211M +$29.1M +16% Oct 1, 2018 Dec 31, 2018 10-KT 2021-03-16
Q3 2018 $728M $201M +$106M +112% Jul 1, 2018 Sep 30, 2018 10-KT 2021-03-16
Q2 2018 $622M $176M -$4.6M -2.55% Apr 1, 2018 Jun 30, 2018 10-K 2019-08-13
Q1 2018 $626M $169M -$19.9M -10.5% Jan 1, 2018 Mar 31, 2018 10-K 2019-08-13
Q4 2017 $646M $182M +$2.1M +1.17% Oct 1, 2017 Dec 31, 2017 10-K 2019-08-13
Q3 2017 $644M $94.8M -$77M -44.8% Jul 1, 2017 Sep 30, 2017 10-K 2019-08-13
Q2 2017 $721M $181M +$29.8M +19.7% Apr 1, 2017 Jun 30, 2017 10-K 2018-08-24
Q1 2017 $691M $189M +$41.3M +27.9% Jan 1, 2017 Mar 31, 2017 10-K 2018-08-24
Q4 2016 $650M $180M +$31.4M +21.2% Oct 1, 2016 Dec 31, 2016 10-K 2018-08-24
Q3 2016 $619M $172M +$31.6M +22.5% Jul 1, 2016 Sep 30, 2016 10-K 2018-08-24
Q2 2016 $587M $151M -$2.7M -1.76% Apr 1, 2016 Jun 30, 2016 10-K 2018-08-24
Q1 2016 $590M $148M +$3.6M +2.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 $586M $148M $0 0% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-08
Q3 2015 $586M $140M -$2.7M -1.89% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 $589M $154M +$18.1M +13.3% Apr 1, 2015 Jun 30, 2015 10-K 2018-08-24
Q1 2015 $571M $144M +$16.7M +13.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q4 2014 $554M $148M +$27M +22.3% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-03
Q3 2014 $527M $143M +$23.3M +19.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 $504M $136M +$27.3M +25.2% Apr 1, 2014 Jun 30, 2014 10-K 2016-08-10
Q1 2014 $476M $128M +$29.1M +29.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $447M $121M +$27.5M +29.4% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-04
Q3 2013 $420M $120M +$34.7M +40.9% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 $385M $108M +$22.6M +26.3% Apr 1, 2013 Jun 30, 2013 10-K 2015-08-12
Q1 2013 $363M $98.6M +$14.9M +17.8% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 $348M $93.6M +$16.2M +21% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-05
Q3 2012 $332M $84.9M +$15.9M +23% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $316M $85.7M +$20M +30.5% Apr 1, 2012 Jun 30, 2012 10-K 2014-08-13
Q1 2012 $296M $83.7M +$23.1M +38.2% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 $273M $77.3M +$15.5M +25% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-06
Q3 2011 $257M $69M +$12.7M +22.6% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $244M $65.6M Apr 1, 2011 Jun 30, 2011 10-K 2013-08-14
Q1 2011 $60.6M +$2.95M +5.11% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-02
Q4 2010 $61.9M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-01
Q3 2010 $56.3M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-02
Q1 2010 $57.6M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.